|
Volumn 57, Issue SUPPL. 1, 2002, Pages 34-39
|
Children with type 2 diabetes: The risks of complications
|
Author keywords
Children; Insulin; Metformin; Sulphonylurea; Treatment; Type 2 diabetes
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ACARBOSE;
ANTIDIABETIC AGENT;
AUTOANTIBODY;
C PEPTIDE;
GLUCOSIDASE INHIBITOR;
HEMOGLOBIN A1C;
INSULIN;
METFORMIN;
REPAGLINIDE;
SULFONYLUREA;
TETRAHYDROLIPSTATIN;
UNCLASSIFIED DRUG;
BLOOD GLUCOSE MONITORING;
CARDIOVASCULAR DISEASE;
CELL FUNCTION;
CHILDHOOD DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIABETIC KETOACIDOSIS;
DIET;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
DRUG SAFETY;
DYSLIPIDEMIA;
EXERCISE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RESISTANCE;
LIFESTYLE;
MATURITY ONSET DIABETES MELLITUS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
OVARY POLYCYSTIC DISEASE;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
CHILD, PRESCHOOL;
DIABETES MELLITUS, TYPE 2;
DISEASE PROGRESSION;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
METFORMIN;
RISK ASSESSMENT;
SULFONYLUREA COMPOUNDS;
|
EID: 0036234793
PISSN: 03010163
EISSN: None
Source Type: Journal
DOI: 10.1159/000053310 Document Type: Conference Paper |
Times cited : (29)
|
References (13)
|